Covid and flu protection in one vaccine? Corona vaccine pioneers next big aim
Pfizer-BioNTech said that they will test a combined vaccine, which could potentially pave the way for better inoculation uptake for two illnesses. Here is what the companies are up to
An early-stage study to assess a combination vaccine targeting COVID-19 and influenza has been launched by U.S. pharmaceutical company Pfizer Inc. and its German partner BioNTech SE, according to an announcement made on Thursday.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more